Wigen Biomedicine Technology (Shanghai) Co. Ltd. has divulged compounds acting as histone deacetylase 1 (HDAC1) and/or 2 (HDAC2) inhibitors reported to be useful for the treatment of cancer.

Suzhou Puhe Biopharma Co. Ltd. has disclosed histone deacetylase 1 (HDAC1) inhibitors acting as REST Corepressor 1 (RCOR1; CoREST)/histone deacetylase (HDAC) complex inhibitors reported to be useful ...

Expression levels of HDAC2, but not of HDAC1 or HDAC3, were decreased 24 ... Infusion of the HDAC inhibitors vorinostat (a class I and II HDAC inhibitor) or MS-275 (a class I HDAC inhibitor ...